PT80635B - PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT - Google Patents

PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT

Info

Publication number: PT80635B
Authority: PT; Portugal
Prior art keywords: preparation; galenic form; delayed effect; new galenic; new
Prior art date: 1984-06-14

Application number

PT80635A

Other languages

Portuguese (pt)

Other versions

PT80635A (en

Inventor

Wolfgang Czarnecki

Jean Claude Gfeller

Hans Peter Bier

Original Assignee

Sandoz Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-14

Filing date

1985-06-12

Publication date

1987-10-20

1985-06-12 Application filed by Sandoz Sa filed Critical Sandoz Sa

1985-07-01 Publication of PT80635A publication Critical patent/PT80635A/en

1987-10-20 Publication of PT80635B publication Critical patent/PT80635B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PT80635A 1984-06-14 1985-06-12 PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT PT80635B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3422083		1984-06-14
DE3442566		1984-11-22

Publications (2)

Publication Number	Publication Date
PT80635A PT80635A (en)	1985-07-01
PT80635B true PT80635B (en)	1987-10-20

Family

ID=25822108

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT80635A PT80635B (en)	1984-06-14	1985-06-12	PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT

Country Status (21)

Country	Link
AT (1)	AT391806B (en)
AU (2)	AU587190B2 (en)
BE (1)	BE902626A (en)
CA (1)	CA1264441A (en)
CY (1)	CY1635A (en)
DE (1)	DE3520184C2 (en)
DK (1)	DK167649B1 (en)
ES (1)	ES8702141A1 (en)
FR (1)	FR2565822B1 (en)
GB (3)	GB2160100B (en)
GR (1)	GR851430B (en)
HK (1)	HK25192A (en)
HU (1)	HU198844B (en)
IE (1)	IE58834B1 (en)
IL (1)	IL75490A0 (en)
IT (1)	IT1200080B (en)
LU (1)	LU85946A1 (en)
NL (1)	NL194389C (en)
NZ (1)	NZ212390A (en)
PT (1)	PT80635B (en)
SE (1)	SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1187751B (en) *	1985-10-15	1987-12-23	Eurand Spa	PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
WO1989009066A1 (en) *	1988-03-24	1989-10-05	Bukh Meditec A/S	Controlled release composition
GR1000270B (en) *	1988-09-30	1992-05-12	Alza Corp	Dose for cardiovascular troubles therapy
DK469989D0 (en) *	1989-09-22	1989-09-22	Bukh Meditec	PHARMACEUTICAL PREPARATION
MX9300110A (en) *	1992-01-13	1994-07-29	Gerhard Gergely	PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) *	1992-01-17	1993-07-22	Alfatec Pharma Gmbh	Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5773025A (en)	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en)	1993-09-09	2004-04-27	Penwest Pharmaceuticals Co.	Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
ES2322405T3 (en)	1996-07-08	2009-06-19	Penwest Pharmaceuticals Co.	CONTROLLED LIBERATION MATRIX FOR INSOLUBLE DRUGS IN HIGH DOSE.
DE19710009A1 (en) *	1997-03-12	1998-09-24	Knoll Ag	Multi-phase preparation forms containing active ingredients
US6056977A (en)	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en)	1998-03-10	2004-09-07	Abbott Laboratories	Multiphase active ingredient-containing formulations
AU5483600A (en) *	1999-06-11	2001-01-02	Jean A. Chmielewski	Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en)	1999-06-11	2006-02-21	Purdue Research Foundation	Pharmaceutical materials and methods for their preparation and use
HU229295B1 (en) *	1999-08-04	2013-10-28	Astellas Pharma Inc	Stable medicinal compositions for oral use
CN1228043C (en)	1999-09-30	2005-11-23	爱德华·孟岱尔股份有限公司	Extended-release matrices for highly soluble drugs
CA2434542A1 (en) *	2001-02-13	2002-08-22	Anne Juppo	Novel modified release formulation
US7135436B2 (en)	2003-05-05	2006-11-14	J.F. Daley International, Ltd.	Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en)	2005-02-11	2006-08-16	Abbott GmbH & Co. KG	Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
EP2500015A1 (en)	2006-12-05	2012-09-19	Landec Corporation	Delivery of drugs
US8399007B2 (en)	2006-12-05	2013-03-19	Landec Corporation	Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en)	2007-12-04	2012-02-14	Landec Corporation	Polymer formulations for delivery of bioactive materials
CN102271661A (en)	2008-08-20	2011-12-07	德克萨斯州立大学董事会	Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617362A1 (en) *	1967-11-17	1971-03-25	Beiersdorf Ag	Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) *	1974-01-09	1982-04-22	Bayer Ag, 5090 Leverkusen	Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) *	1975-10-17	1981-04-02	Sandoz-Patent-GmbH, 7850 Lörrach	Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) *	1975-11-17	1978-03-22	Sandoz Ltd	Tablet formulations
GB1579818A (en) *	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
CH639659A5 (en) *	1978-12-18	1983-11-30	Sandoz Ag	NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DK149855C (en) *	1977-06-20	1987-04-21	Sandoz Ag	METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
EP0001247A1 (en) *	1977-09-14	1979-04-04	Kanebo, Ltd.	Pharmaceutical preparation containing nifedipine and a method for producing the same.
SE442265B (en) *	1978-12-21	1985-12-16	Sandoz Ag	FIXED, ENTERAL TRANSFER COMPOSITION IN UNIT FORM ORAL SUPPLY INCLUDING AN ERGOTAL KALOID
DE2904310A1 (en) *	1979-02-05	1980-08-07	Boehringer Mannheim Gmbh	MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) *	1980-02-20	1981-09-11	Kaken Pharmaceut Co Ltd	Pharmaceutical containing nifedipine
DE3033919A1 (en) *	1980-09-09	1982-04-22	Bayer Ag, 5090 Leverkusen	SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) *	1981-09-02	1984-04-10	Sandoz Ltd.	Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) *	1981-10-29	1986-05-28	Bayer Ag	Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) *	1982-10-07	1986-07-29	Kazuo Kigasawa	Soft buccal
DE3318649A1 (en) *	1983-05-21	1984-11-22	Bayer Ag, 5090 Leverkusen	TWO-PHASE FORMULATION

1985
- 1985-05-31 HU HU852126A patent/HU198844B/en unknown
- 1985-05-31 NL NL8501578A patent/NL194389C/en not_active IP Right Cessation
- 1985-06-05 DE DE3520184A patent/DE3520184C2/en not_active Expired - Lifetime
- 1985-06-10 FR FR858508850A patent/FR2565822B1/en not_active Expired
- 1985-06-10 BE BE1/011271A patent/BE902626A/en not_active IP Right Cessation
- 1985-06-12 AT AT0174885A patent/AT391806B/en not_active IP Right Cessation
- 1985-06-12 CA CA000483768A patent/CA1264441A/en not_active Expired
- 1985-06-12 AU AU43486/85A patent/AU587190B2/en not_active Ceased
- 1985-06-12 ES ES544075A patent/ES8702141A1/en not_active Expired
- 1985-06-12 PT PT80635A patent/PT80635B/en unknown
- 1985-06-12 NZ NZ212390A patent/NZ212390A/en unknown
- 1985-06-12 DK DK264785A patent/DK167649B1/en not_active IP Right Cessation
- 1985-06-12 IE IE146085A patent/IE58834B1/en not_active IP Right Cessation
- 1985-06-12 GR GR851430A patent/GR851430B/el unknown
- 1985-06-12 IL IL75490A patent/IL75490A0/en not_active IP Right Cessation
- 1985-06-12 GB GB8514855A patent/GB2160100B/en not_active Expired
- 1985-06-13 SE SE8502950A patent/SE504583C2/en not_active IP Right Cessation
- 1985-06-13 IT IT8548210A patent/IT1200080B/en active
- 1985-06-13 LU LU85946A patent/LU85946A1/en unknown
1987
- 1987-11-19 GB GB8727055A patent/GB2196851B/en not_active Expired
- 1987-11-19 GB GB8727056A patent/GB2196852B/en not_active Expired
1989
- 1989-11-09 AU AU44543/89A patent/AU4454389A/en not_active Abandoned
1992
- 1992-04-02 HK HK251/92A patent/HK25192A/en not_active IP Right Cessation
- 1992-11-06 CY CY1635A patent/CY1635A/en unknown

Also Published As

Publication number	Publication date
IE58834B1 (en)	1993-11-17
GB8514855D0 (en)	1985-07-17
BE902626A (en)	1985-12-10
GB2196851A (en)	1988-05-11
GB2196852A (en)	1988-05-11
GR851430B (en)	1985-11-25
FR2565822A1 (en)	1985-12-20
NL194389B (en)	2001-11-01
AU587190B2 (en)	1989-08-10
HU198844B (en)	1989-12-28
IE851460L (en)	1985-12-14
IT8548210A0 (en)	1985-06-13
PT80635A (en)	1985-07-01
NL194389C (en)	2002-03-04
GB8727055D0 (en)	1987-12-23
SE8502950D0 (en)	1985-06-13
DK264785A (en)	1985-12-15
ES8702141A1 (en)	1987-01-01
AU4348685A (en)	1985-12-19
AU4454389A (en)	1990-03-22
GB2160100B (en)	1989-06-01
ES544075A0 (en)	1987-01-01
GB2160100A (en)	1985-12-18
IL75490A0 (en)	1985-10-31
ATA174885A (en)	1990-06-15
DE3520184C2 (en)	1997-03-13
FR2565822B1 (en)	1989-02-17
NZ212390A (en)	1992-02-25
NL8501578A (en)	1986-01-02
HUT40918A (en)	1987-03-30
DK264785D0 (en)	1985-06-12
GB2196852B (en)	1989-05-17
CY1635A (en)	1992-11-06
GB2196851B (en)	1989-06-07
DE3520184A1 (en)	1985-12-19
LU85946A1 (en)	1986-01-24
SE8502950L (en)	1985-12-15
DK167649B1 (en)	1993-12-06
SE504583C2 (en)	1997-03-10
GB8727056D0 (en)	1987-12-23
IT1200080B (en)	1989-01-05
AT391806B (en)	1990-12-10
CA1264441A (en)	1990-01-16
HK25192A (en)	1992-04-10

Publication	Publication Date	Title
PT80635B (en)	1987-10-20	PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT
PT80916B (en)	1987-12-30	PROCESS FOR THE PREPARATION OF A NEW MODIFICATION OF CRYSTALS
PT80573B (en)	1987-08-19	PROCESS FOR THE PREPARATION OF RECOMBINANT LINFOTOXIN
PT80247B (en)	1987-10-20	METHOD FOR THE PREPARATION OF A STABLE INTERLEUKIN-2 COMPOSITION
BR8500141A (en)	1985-08-20	PROCESS FOR THE PREPARATION OF COTELLOMER COMPOUNDS
BR8501583A (en)	1985-12-03	PROCESS FOR THE PREPARATION OF COMPOUNDS
PT81463B (en)	1988-03-03	PROCESS FOR THE PREPARATION OF NEW DERIVATIVES 5-AMINO-4-HYDROXYVALERYL
BR8604182A (en)	1987-04-28	PROCESS FOR THE PRODUCTION OF ETERES
BR8500422A (en)	1985-09-10	PROCESS FOR THE PREPARATION OF POLYISOCIANATES WITH BIURET STRUCTURE
BR8406105A (en)	1985-09-24	PROCESS FOR THE PRODUCTION OF A NITRODIARYLAMINES
PT81714B (en)	1988-04-21	PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS OF THEOPHILINE WITH DELAYED EFFECT
PT81356B (en)	1987-11-11	PROCESS FOR THE PREPARATION OF AN ANTI-VEGETATIVE INK
PT81393B (en)	1988-02-17	PROCESS FOR THE PREPARATION OF OXINDOLIC ANTI-INFLAMMATORY AGENTS
BR8800430A (en)	1988-10-11	PROCESS FOR THE PREPARATION OF A THERMOPLASTIC COMPOSITION
BR8501588A (en)	1985-12-03	PROCESS FOR THE PREPARATION OF POLYISOCIANATES
BR8505989A (en)	1986-08-19	PROCESS FOR THE PREPARATION OF AMINO-4-DIPHENYLAMINS
BR8502305A (en)	1986-01-21	PROCESS FOR THE PREPARATION OF ORGANOPOL ISSILOXANAS ORGANOFUNCIONAL
BR8501134A (en)	1985-11-12	PROCESS FOR THE PREPARATION OF GLYCIDITERES
PT81061B (en)	1987-11-11	PROCESS FOR THE PREPARATION OF A VACINAL POLIPEPTIDEO
IT1199413B (en)	1988-12-30	PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE
PT81487B (en)	1987-12-30	PROCESS FOR THE PREPARATION OF NEW TIENOPYRIDINE DERIVATIVES
PT80634B (en)	1987-10-20	PROCESS FOR THE PREPARATION OF NAFTOXACINS
PT80517B (en)	1987-11-11	Process for the preparation of a composition containing CHA extract
BR8505146A (en)	1986-07-29	PROCESS FOR THE PREPARATION OF ZSM-23 ZEOLITE
BR8504162A (en)	1986-06-24	PROCESS FOR THE PREPARATION OF CHLORINE-O-NITROANILINS

Legal Events

Date	Code	Title	Description
1998-01-30	PC3A	Transfer or assignment	Free format text: 971017 NOVARTIS AG CH